Home
>
ipos-overview
Proposed Symbol | PACHU |
---|---|
Company Name | Pioneer Acquisition I Corp |
Exchange | NASDAQ Global |
Share Price | $10.00 |
Employees | 1 (as of 06/20/2025) |
Status | Priced |
Shares Offered | 22,000,000 |
Offer amount | $220,000,000 |
Shares Over Alloted | |
Company Address | 131 CONCORD STREET BROOKLYN NY 11201 |
Company Phone | 3477202907 |
Company Website | www.carislifesciences.com |
CEO | Mitchell Creem |
State of Inc | |
Fiscal Year End | 12-31 |
Total Offering Expense | $575,000.00 |
Shareholder Shares Offered | |
Shares Outstanding | 27,500,000 |
Lockup Period (days) | 180 |
Lockup Expiration | 2025-12-15 00:00:00 |
Quiet Period Expiration | 2025-07-28 00:00:00 |
CIK | 0002040381 |
DealId | 1337260-114150 |
We are a blank check company incorporated as an exempted company under the laws of the Cayman Islands on August 28, 2024, which will seek to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, which we refer to throughout this prospectus as our initial business combination. While we may pursue an acquisition opportunity in any business, industry, sector or geographical location, we intend to focus on industries that complement our management team’s and board of director’s background and network, and to capitalize on the ability of our management team and board of directors to identify and acquire a business, focusing on the healthcare or healthcare related industries. To date, our efforts have been limited to organizational activities as well as activities related to this offering. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us. We have generated no operating revenues to date and we do not expect that we will generate operating revenues until we consummate our initial business combination. Our management team is comprised of individuals who bring a wealth of experience across diverse domains, including the healthcare sector, financial services, capital markets, special purpose acquisition companies, mergers and acquisitions, private equity, and leadership roles in publicly traded firms. Each member of our team has a robust professional background that spans several decades, and their collective expertise covers a broad spectrum of industries. --- Our executive offices are located at 131 Concord Street, Brooklyn, New York, 11201, and our telephone number is 347-720-2907.